Up-Regulation of Hexokinase II (HK) Alters the Glucose Metabolism and Disrupts the Mitochondrial Potential in Aggressive B-Cell Lymphoma Contributing to Rituximab-Chemotherapy Resistance and Is a Clinically Relevant Target for Future Therapeutic Development

Autor: Gu, Juan J *, Singh, Anil *, Mavis, Cory *, Yanamadala, Vivek *, Xue, Kai *, Grau, Michael *, Lenz, Peter *, Lenz, Georg, Czuczman, Myron S., Hernandez, Francisco
Zdroj: In Blood 6 December 2014 124(21):1767-1767
Databáze: ScienceDirect